CAS 943-17-9|Efortil
| Common Name | Efortil | ||
|---|---|---|---|
| CAS Number | 943-17-9 | Molecular Weight | 217.69 |
| Density | 1.127g/cm3 | Boiling Point | 351.7ºC at 760 mmHg |
| Molecular Formula | C10H16ClNO2 | Melting Point | 122ºC |
| MSDS | / | Flash Point | 155.5ºC |
| Symbol | GHS06 | Signal Word | Danger |
Names
| Name | 3-[2-(ethylamino)-1-hydroxyethyl]phenol,hydrochloride |
|---|---|
| Synonym | More Synonyms |
Efortil BiologicalActivity
| Description | Etilefrine hydrochloride is an orally active α adrenergic agonist. Etilefrine hydrochloride is also an AMPK activator. Etilefrine hydrochloride can be used for the research of postural hypotension[1][2][3][4]. |
|---|---|
| Related Catalog | Signaling Pathways >>Epigenetics >>AMPKResearch Areas >>Cardiovascular DiseaseSignaling Pathways >>GPCR/G Protein >>Adrenergic ReceptorSignaling Pathways >>PI3K/Akt/mTOR >>AMPK |
| References | [1]. Sylvain Tollis, et al. Chemical Interrogation of Nuclear Size Identifies Compounds with Cancer Cell Line-Specific Effects on Migration and Invasion. ACS Chem Biol. 2022 Feb 24. [2]. Chi Xu, et al. Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes. Cell Rep. 2018 Oct 9;25(2):523-535.e5. [3]. R Yamazaki, et al. Effects of dihydroergotamine and Etilefrine on experimentally-induced postural hypotension in dogs. J Pharmacobiodyn. 1990 Sep;13(9):519-24. [4]. Bouaggad A, et al. The effect of oral etilefrine premedication on the incidence of hypotension during spinal anaesthesia. Eur J Anaesthesiol. 2000 Mar;17(3):177-81. |
Chemical & Physical Properties
| Density | 1.127g/cm3 |
|---|---|
| Boiling Point | 351.7ºC at 760 mmHg |
| Melting Point | 122ºC |
| Molecular Formula | C10H16ClNO2 |
| Molecular Weight | 217.69 |
| Flash Point | 155.5ºC |
| Exact Mass | 217.086960 |
| PSA | 52.49000 |
| LogP | 2.22800 |
| InChIKey | KTNROWWHOBZQGK-UHFFFAOYSA-N |
| SMILES | CCNCC(O)c1cccc(O)c1.Cl |
| Water Solubility | Freely soluble in water, soluble in ethanol (96 per cent), practically insoluble in methylene chloride |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 187 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,413,1979
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >420 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,187,1990
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,225,1995
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 345 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,413,1979
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 860 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,115,1982
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 11 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,413,1979
Safety Information
| Symbol | GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H319 |
| Precautionary Statements | Missing Phrase - N15.00950417-P305 + P351 + P338 |
| RIDADR | UN 2811 6.1 / PGIII |
| RTECS | DO5618000 |
| HS Code | 2922509090 |
Customs
| HS Code | 2922509090 |
|---|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Articles24
More Articles| Indications, surgical technique, and long-term experience with laparoscopic closure of the nephrosplenic space in standing horses. Vet. Surg. 34(6) , 637-41, (2005) To describe surgical technique and outcome after laparoscopic closure of the nephrosplenic space for treatment of recurrent left dorsal displacement of the left colon (LDDLC) in standing horses.Retros... | |
| [A complicated course after esophagogastrectomy]. J. Chir. (Paris.) 144(3) , 241-5, (2007) | |
| Priapism in a patient with unstable hemoglobin: hemoglobin Köln. Am. J. Hematol. 74(1) , 73-4, (2003) We report a case of severe priapism occurring in a patient with unstable hemoglobin, hemoglobin Köln, and underline several factors that may have contributed to this complication: abnormal plasticity ... |
Synonyms
| etilefrine hydrochloride |
| Effortil |
| α-[(Ethylamino)methyl]-3-hydroxybenzenemethanol hydrochloride |
| N-Ethyl-1-(m-hydroxyphenyl)-2-aminoethanol hydrochloride |
| 3-[2-(ethylamino)-1-hydroxyethyl]phenol hydrochloride |
| Thomasin |
| Benzenemethanol, α-[(ethylamino)methyl]-3-hydroxy-, hydrochloride (1:1) |
| Effortil*HCl |
| EINECS 213-398-8 |
| Etilefrin-HCl |
| 3-[2-(Ethylamino)-1-hydroxyethyl]phenol hydrochloride (1:1) |
| Etilefrin dl-form hydrochloride |
| Cardanat |
| Etilefrine HCl |
| Effontil |
| Efortil |
| Circupon |
